In another study, strong protection against liver fibrosis was observed in hepatocytes after KD3010 (PPARδ activation ligand) administration, whilst GW501516 had no effect on the fibrotic changes in the same model [57]. The gene discussed is PPARD; the disease is Hepatic fibrosis.